Therefore, while TNF-α becomes a key target for therapeutic intervention in a redundant cytokine environment, improper inhibition may result in an increased risk of new TB infection, reactivation of latent TB, predisposition to opportunistic infections such as candida or aspergillus, or even a flare-up of viral infections [6]. This evidence concerns the gene TNF and viral infectious disease.